$39.51
Currently 22 wall-street analysts regularly analyze the financials of Moonlake Immunotherapeutics on a frequent basis to provide recommendations along with target share price. 22 analysts offering 12-month price forecasts for Moonlake Immunotherapeutics (MLTX) have a share price target of $77.77. This median of share price forecast represents a 96.83% upside from the latest price of $39.51 as on 25.04.25.
As per the chart shown above, analysts believe that the Moonlake Immunotherapeutics (MLTX) share price will touch around $77.77 in next 12-months.
Below is a chart showing the percentage difference between Moonlake Immunotherapeutics's share price and its median forecast price. As on 25.04.25, the difference is -53.26%
Based on 22 analysts tracking and researching Moonlake Immunotherapeutics (MLTX) share have buy recommendation on an average.
3M Ago | 1M Ago | Current | |
Buy | 8 | 8 | 8 |
Outperform | 9 | 10 | 10 |
Hold | 3 | 3 | 4 |
Underperform | 0 | 0 | 0 |
Sell | 0 | 0 | 0 |